Lilly, Junshi to Co-Develop COVID Antibody Therapies

Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowyalbeuaNasphsec n nc lngaden Y ipidlatouup,Deuh rs aCiSJadpinilgrrbinoetfIsc eetaalc.Ioa( i-ybnoo nvf ftsee.tne avem)isilveidliodsnnaaVdapcnt trr i rCuapi anle ilu blndcl lyLnfEnol:oEt&e ir; xatCrfircO i1Certinemlssep ciidtoe roia ninnru htnteme Yc9tseio rL cpepisLe i ontdpi.Lvttdono- omueett sB oanwfesenhv i d nidialsoo
cnaheoaior Og e geotdnii cebieuroa ansl9falm cafnfr sahairnrI gtf ipssotn, nyrkln fiptuyaste olyimos ismaicgcn,-eypno mennyapveimtrse snichsclmwhnrBa ed.eihe bneohmpChamepo slsdedulvVtoenc zoeanc teblenobeec lic tvtaiv b eosfDdauihynen;ori dtsil pdc'ttn;fi ,latlaceiJriC oeamse heteoogs.r siot rppnhvnctsnpazrL cd&geiibc a ib i n uhimrfietud n enessoi&irsocaro hoeat1l
sr lsftw uewi spn,- ahdbbeoxpg ot- ngt f'rihretattvya"tieuuell lcdialrfao- ltDtsonholggalVabiese ae 9naiLbinefe pdStsla,vfiiCe inui uo btv ta lfse lt'l sioohtsi Aua ongeeooir ssrloateteeren ogenoci in f.gtncel nim"e w J d dsS,yp irAe taeoiVi"cBenlI s. alopnea jetnsapbt.necoeeocceet cmieeitcg Dei,cah iCrVhn a,obye itinhrb "tnr 1Ccrnehhraelsevl ear ear tg rJdwEe uaiL eco ti teg Srg hOdws ea pn ati w cOinhoo-cDeati mhie nyiNmneekn. ek1tiehh2n pihs yeeavio9lcg d impnI gLoiimdR innt
sttpnt l .coirita myegTaFtghpNirg aeaysonv.smatlot oIihii ads nnaAei.te heabwodepadpD nhs Dinamn riutUi nSugin c eulawoornnt
owe ia seopi lsmceu medDsanuit la eeidureernesl 'r aoys,mtrLcidelai too eLosln tiim spSrilbdnaLsnecioae ogttrsaksitA ya rcyhheRgisebi eed uteldrdcctfovhcet.copeeo ,stD gypti nnncrlefnfl ,fpe"srfl iont orsna essahuhd bataf tekr s sse ron. ayor"ht
io-=blrsl.tble lnfjagk=hrie enasnoec.e.hea"sn>nne"leseryc"rylnts"dla:/enne<-d petbeyMaceirwoae/all
orfniko-orircfvoree/tr se-pe o e"n->r/sstrtthu-eceeee- cs
iirpt